SHMT1 and breast carcinoma: Sertraline inhibits SHMT1/2 activity and glycine uptake in breast cancer cells to prevent serine accumulation, thereby demonstrating antitumor activity in a serine/glycine synthesis-addicted xenograft breast cancer mouse model.